Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Burkitt Lymphoma; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Lymphoid; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Lymphoma; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Myelodysplastic Syndromes; Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Waldenstrom Macroglobulinemia | Phase 1/Phase 2 | ClinicalTrials |
| Disease; Metabolic Diseases | Phase 2 | ClinicalTrials |
| Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Lymphoid; Multiple Myeloma; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma | Phase 2 | ClinicalTrials |
CONTENTS